It is necessary to increase knowledge about the safety and effectiveness of influenza vaccination during pregnancy to improve awareness among patients and healthcare professionals and increase to increase vaccination coverage.

Recent scientific advancements enabled the accelerated development, production, and evaluation of COVID-19 vaccines, leveraging novel technologies that are estimated to have prevented approximately 1.6 million hospitalizations and 235.000 deaths in the US

Frequency, phenotype and T-cell receptor (TCR) composition of influenza-specific CD8+ T-cells directed at the prominent A2/M158 influenza epitope change across the human lifespan.

Immunisation with life-saving vaccines is one of the greatest achievements in public health, but a growing wave of misinformation/disinformation in the wake of the COVID-19 pandemic threatens to undermine the many successes of vaccination.

The two influenza B virus (FLUBV) lineages have continuously diverged from each other since the 1980s, with recent (post-2015) viruses exhibiting accelerated evolutionary rate.

Immunosenescence, age-related immune dysregulation, reduces immunity upon vaccinations and infections.

Pregnant women with COVID-19 are more likely to develop severe COVID-19 and related ill health than non-pregnant women of similar age.

A new joint action focusing on tackling chronic respiratory diseases was recently launched. Backed by the EU4Health programme, the 3-year initiative aims to improve lung health across Europe through innovative digital health technologies.